Fertility warning
This medicine may affect fertility.
Leaflet TORISEL 25mg / ml concentrate and solvent for solution for infusion
- Product code:
- W52721001
- Quantity:
- 1
- Indicated for:
- cancer
- Route of administration:
- infusion
- Substance:
- temsirolimus (antineoplastic agent)
- ATC
- L01EG01 — Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Mammalian target of rapamycin (MTOR) kinase inhibitors
Precautions:
Dose adjustment in hepatic impairment
Dose adjustment may be needed in liver disease.
Cytotoxic / special handling
Handle with special care.
Contraception required
Effective contraception is required during treatment.
Contraindicated during breastfeeding
Do not use this medicine while breastfeeding.
Contraindicated during pregnancy
Do not use this medicine during pregnancy.
Avoid grapefruit
Avoid grapefruit and grapefruit juice.
Avoid live vaccines
Avoid live vaccines during treatment if contraindicated.
Hepatotoxicity
This medicine may affect the liver.
Immunosuppression / infection risk
This medicine may increase the risk of infections.
Major drug interactions
This medicine may have important interactions with other medicines.
Myelosuppression / agranulocytosis
This medicine may lower blood cell counts.
Additional monitoring
This medicine is subject to additional monitoring.
Requires periodic laboratory tests
Periodic laboratory tests may be required during treatment.
Severe skin reactions
Stop taking the medicine and seek urgent medical help if a severe rash occurs.
Temsirolimus is an mTOR (mammalian target of rapamycin) inhibitor used for the treatment of advanced renal cancer and other types of tumors. It works by inhibiting the growth and proliferation of tumor cells, thereby reducing disease progression.
The medication is administered via intravenous infusion, usually once a week, as directed by a doctor. It is important for patients to be closely monitored during treatment to prevent potential complications.
Patients should be aware of potential side effects, such as skin rashes, fatigue, or elevated blood glucose levels. It is important to inform the doctor of any unusual symptoms.
Common side effects include skin rashes, fatigue, nausea, and increased cholesterol or glucose levels. In rare cases, severe reactions such as serious infections or kidney failure may occur. Patients should be informed of these risks before starting treatment.
The medication is administered via intravenous infusion, usually once a week, as directed by a doctor. It is important for patients to be closely monitored during treatment to prevent potential complications.
Patients should be aware of potential side effects, such as skin rashes, fatigue, or elevated blood glucose levels. It is important to inform the doctor of any unusual symptoms.
Common side effects include skin rashes, fatigue, nausea, and increased cholesterol or glucose levels. In rare cases, severe reactions such as serious infections or kidney failure may occur. Patients should be informed of these risks before starting treatment.
General data about TORISEL 25mg / ml
- Substance:
- temsirolimus
- Date of latest medicines list:
- 01-10-2015
- Product code:
- W52721001
- Concentration:
- 25mg / ml
- Pharmaceutical form:
- concentrate and solvent for solution for infusion
- Quantity:
- 1
- Product type:
- Original
- Prescription status:
- S — Medicines dispensed with a restricted medical prescription, reserved for use in certain specialized fields.
Concentrations available for temsirolimus
- 25mg/ml
- 30mg